Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Graves' disease

Graves' disease

Subtypes of Graves' disease

Thyroid eye disease 2 Graves orbitopathy 1 Thyroid-associated ophthalmopathy 1

13 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Graves' disease

7 trials tracked for Graves' disease: 2 in phase 3 or 4.

7Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 3 1 Phase 2 3 Phase 1 1 Other / NA 1
  1. Phase 4 Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease Completed
  2. Phase 3 Early Levothyroxine Post Radioactive Iodine Completed
  3. Phase 2 A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease Completed
  4. Phase 2 Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients Completed
  5. Phase 2 Radioactive Iodide Therapy for Pediatric Graves' Disease Completed
  6. Phase 1 ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy Completed
Show 1 more trials
  1. N/A Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Antithyroid drug-induced agranulocytosis patients show distinct T-cell receptor repertoires compared to Graves' disease patients
Allergy & Immunology
Antithyroid drug-induced agranulocytosis patients show distinct T-cell receptor repertoires compared to Graves' disease patients Why Your Thyroid Meds Might Trigger Rare Infections
This observational study compared immune receptor repertoires in patients with antithyroid drug-induced agranulocytosis (TiA) versus those w…
A rare but deadly reaction to thyroid drugs is linked to specific immune cell changes, offering clues to predict who's at risk before infect…
medRxiv Apr 14, 2026

Questions about Graves' disease

Can IVIg and efgartigimod help a man with Graves disease and Guillain-Barré syndrome?

A case report shows a man with Graves disease and Guillain-Barré syndrome improved with IVIg and efgartigimod, but surgery was also needed after finding thyroid cancer.

Full answer →